-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.0019900% Upside
Calithera Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Calithera Biosciences, Inc.?
Calithera Biosciences, Inc. has been rated by research analysts at Leerink Partners in the past 90 days.